Investors
Elan Offers Profit Return to Shareholders
Elan profits from Tysabri sale offered to shareholders. Elan, the Irish drug firm has announced it would return US$1 billion to its shareholders from the proceeds of the sale of its stake in multiple sclerosis drug Tysabri to partner Biogen Idec.
OMERS' Asset Rise Prompts Shopping Spree
Canada's OMERS pension fund poised to make major purposes in 2013. OMERS, one of Canada's leading pension funds, announced last Friday that it is now in the process of diversifying its portfolio away from traditional areas such as North America, the United Kingdom and Western Europe.
RBS to Draft Citizens Financial IPO
RBS to sell its stake in Citizens Financial through an IPO In a news report from the Telegraph, the Royal Bank of Scotland is to announce its plans to sell a portion of its interests in US retail banker Citizens Financial Group Inc.
ENI Partners with Rosneft on Logistics
ENI shipping and logistics to bring Rosneft oil to markets worldwide. ENI, the Italian gas and oil giant, has entered into a strategic partnership with Rosneft to explore trading and logistics opportunities in the energy market.




